KOL KnockoutTM: Cataract Edition — Improving Postoperative O -

Overview
This fun and exciting CME program is a game show-style quiz competition that features key opinion leaders (KOLs) as contestants. Hosted by Program Chair Gary Wörtz, MD, the second of three rounds will feature Ashley Brissette, MD, MSc, FRCSC; Robert J. Weinstock, MD (Round 1 Champion); and William F. Wiley, MD, as contestants.

The program includes a brief presentation followed by patient case studies and each KOL weighs in on the treatment options.
There will be learning, laughter, and only one KOL left standing!
This activity is supported by an unrestricted medical educational grant from Alcon Vision.
Learning Objectives
Upon completion of this activity, the participant should be able to:
- Identify the potential benefits and drawbacks of using femtosecond laser technology for cataract and refractive surgery
- Discuss advances in adjunctive technologies for cataract surgery and how they can be used to improve refractive outcomes
- Compare advanced intraocular lenses for cataract and refractive surgery patients to properly counsel patients and create personalized treatment plans based on patient expectations
Accreditation
Provided by Evolve Medical Education
Evolve is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Evolve designates this live activity for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Successful completion of this CME activity, which includes participation in the evaluation component, earns credit toward the Lifelong Learning requirement[s] for the American Board of Ophthalmology’s Continuing Certification program. It is the CME activity provider's responsibility to submit learner completion information to ACCME for the purpose of granting credit.
Participation Method
In order to obtain credit, proceed through the program, complete the post-test, evaluation and submit for credit.
Faculty and Disclosures
Gary Wörtz, MD
Private practice
Commonwealth Eye Surgery
Lexington, KY

Ashley Brissette, MD, MSc, FRCSC
Assistant Professor of Ophthalmology
Weill Cornell Medicine
New York Presbyterian Hospital
New York, NY

Robert J. Weinstock, MD
Private Practice
The Eye Institute of West Florida
Largo, FL

William F. Wiley, MD
Medical Director
Cleveland Eye Clinic
Division of Midwest Vision Partners
Cleveland, OH

DISCLOSURE POLICY
It is the policy of Evolve that faculty and other individuals who are in the position to control the content of this activity disclose any real or apparent financial relationships relating to the topics of this educational activity. Evolve has full policies in place that will identify and mitigate all financial relationships prior to this educational activity.
The following faculty/staff members have the following financial relationships with ineligible companies.
Gary Wörtz, MD, has had a financial relationship or affiliation with the following ineligible companies in the form of Consultant: Alcon, Bausch + Lomb, Carl Zeiss Meditec, Johnson & Johnson, Lensar, and Ocuphire. Speaker's Bureau: Avellino. Stock/Shareholder: Arcuate Innovations and Omega Ophthalmics.
Ashley Brissette, MD, MSc, FRCSC, has had a financial relationship or affiliation with the following ineligible companies in the form of Consultant: Alcon, Bausch + Lomb, Carl Zeiss Meditec, Glaukos, Johnson & Johnson Vision, Novartis, RxSight, Sun Pharmaceutical Industries, and TearLab. Grant/Research Support: Alcon.
Robert J. Weinstock, MD, has had a financial relationship or affiliation with the following ineligible companies in the form of Consultant: Alcon, Bausch + Lomb, Beyeonics, EyePoint Pharmaceuticals, Johnson & Johnson Vision, Lensar, and Visus. Speaker's Bureau: Johnson & Johnson Vision. Shareholder: Eyesafe, RPS, RxSight, TissueTech, uBeam, and Visus.
William F. Wiley, MD, has had a financial relationship or affiliation with the following ineligible companies in the form of Consultant: Alcon, Allergan, Bausch + Lomb, Carl Zeiss Meditec, Dompé, Imprimis, and RxSight.
The Evolve staff and planners have no financial relationships with ineligible companies.
Nisha Mukherjee, MD, peer reviewer, has no financial relationships with ineligible companies.
Disclaimer
OFF-LABEL STATEMENT
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The opinions expressed in the educational activity are those of the faculty. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
DISCLAIMER
The views and opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of Evolve or Alcon Vision.
System Requirements
- Supported Browsers (2 most recent versions):
- Google Chrome for Windows, Mac OS, iOS, and Android
  Apple Safari for Mac OS and iOS
  Mozilla Firefox for Windows, Mac OS, iOS, and Android
  Microsoft Edge for Windows
- Recommended Internet Speed: 5Mbps+
Publication Dates
Release Date: 08/31/2022
Expiration Date: 09/08/2022

Gary Wörtz, MD

Host

Ashley Brissette, MD, MSc, FRCSC

Guest

Robert J. Weinstock, MD

Guest

William F. Wiley, MD

Guest

Title

Share on ReachMD